4basebio (4BB) Share Price, News & Analysis

Company Overview

4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company offers AVV and Lentivirus manufacturing services for use in gene therapies and vaccines. It also offers access to its targeted non-viral delivery platform, Hermes. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.

Key Stats

• Today's Range: 1,300 to 1,310
• 50-Day Range: 1,250 to 1,500
• 52-Week Range: 520 to 1,820
• Volume: 2 shs
• Average Volume: 4,560 shs
• Market Capitalization: £166.53 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

4BB Stock Analysis - Frequently Asked Questions

How have 4BB shares performed this year?

4basebio's stock was trading at GBX 680 at the beginning of 2024. Since then, 4BB shares have increased by 91.2% and is now trading at GBX 1,300.
View the best growth stocks for 2024 here.

How do I buy shares of 4basebio?

Shares of 4BB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of 4basebio own?

Based on aggregate information from My MarketBeat watchlists, some other companies that 4basebio investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:4BB
• CUSIP: N/A
• CIK: N/A
• Web: www.4basebio.com
• Phone: 44 1223 967 943
• Fax: N/A
• Employees: 101
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.78)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-9,840,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -231.29%
• Return on Assets: -54.30%

Debt

• Debt-to-Equity Ratio: 201.47
• Current Ratio: 2.73
• Quick Ratio: 3.52

Sales & Book Value

• Annual Sales: £311,000.00
• Price / Sales: 535.47
• Cash Flow: GBX 80.85 per share
• Price / Cash Flow: 16.08
• Book Value: GBX (41) per share
• Price / Book: -31.71

Miscellaneous

• Outstanding Shares: 12,810,000
• Free Float: N/A
• Market Cap: £166.53 million
• Optionable: Not Optionable
• Beta: 1.09